Segment Information - Schedule of Performance and Making Key Decisions Regarding Resource Allocation (Details) - USD ($) |
3 Months Ended | 6 Months Ended | |||
|---|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
Dec. 31, 2025 |
|
| Schedule of Performance and Making Key Decisions Regarding Resource Allocation [Abstract] | |||||
| Cash and cash equivalents | $ 1,112,509 | $ 1,112,509 | $ 1,092,055 | ||
| Cash held in the Trust Account | 477,159,386 | 477,159,386 | $ 469,017,981 | ||
| General and administrative costs | 355,143 | $ 48,603 | 782,993 | $ 49,377 | |
| Interest earned on cash held in Trust Account | $ 4,338,720 | $ 8,641,405 | |||
| X | ||||||||||
- Definition Interest earned on cash held in Trust Account. No definition available.
|
| X | ||||||||||
- Definition The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|